Brief: OptiNose - PDUFA Goal Date For Xhance Chronic Rhinosinusitis SNDA Is Dec 16, 2023
Nov 9 (Reuters) - OptiNose Inc OPTN.O :
* OPTINOSE INC - PDUFA GOAL DATE FOR XHANCE CHRONIC
RHINOSINUSITIS
SNDA IS DECEMBER 16, 2023
* OPTINOSE INC - EXPECTS XHANCE NET REVENUES FOR FULL YEAR
OF 2023
TO BE BETWEEN $66.0 TO $70.0 MILLION
* OPTINOSE INC - QTRLY LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX7JmR25
Further company coverage: OPTN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptiNose
See all newsOptiNose Inc reports results for the quarter ended March 31 - Earnings Summary
OptiNose Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: OptiNose Q4 Income From Operations USD 354 Thousand
U.S. RESEARCH ROUNDUP-Darden Restaurants, Nike, Optinose
U.S. STOCKS ON THE MOVE-Accenture, Nike, FedEx